Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques
- 51 Downloads
The administration of two GnRH analogues (buserelin and leuprolide acetate) in long and short protocols was evaluated prospectively. In the long protocol, the analogues were given from day 1 of the cycle for at least 14 days and then hMG administration was started, while in the short protocol the analogues were initiated from cycle day 1, adding hMG from day 3. The patients were divided into four groups according to the protocol used: Group I, buserelin-long; Group II, buserelin-short; Group III, leuprolide-long; and Group IV, leuprolide-short. Serum E2levels on the day of hCG injection and the number of follicles observed, oocytes retrieved, and embryos obtained, as well as implantation rates, were significantly higher (P<0.001) in the long protocols than in the short ones.
Pregnancy rates were similar in all groups, although a trend for better results was observed in buserelin-long compared to buserelin-short. There were no differences in the results achieved with buserelin or leuprolide.
The administration of GnRH analogues (buserelin and leuprolide acetate) in long protocols induced a more intense ovarian response and was associated with significantly higher implantation rates and also a trend for higher pregnancy rates, although this difference was not statistically significant.
Key wordsovarian stimulation gonadotropin-releasing hormone analogues buserelin leuprolide
Unable to display preview. Download preview PDF.
- 1.Smitz J, Ron-El R, Tarlatzis BC: The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centers. Hum Reprod 1992;7(Suppl 1):49–66Google Scholar
- 2.Zeevi D, Younis SJ, Laufer N: Ovulation induction—New approaches. Assist Reprod Rev 1991;1:2–8Google Scholar
- 7.Tarlatzis BC, Bili H: LH-RH analogues and follicular fluid in IVF cycles. Releaser 1992;7(2):3–7Google Scholar
- 13.Tarlatzis BC: Oocyte collection and quality. Assist Reprod Rev 1992;2:16–22Google Scholar
- 14.Hedon B, Arnal F, Basor E, Boulot P, Huet JM, Fries N, Deschamps F, Cristal P, Humeau C: Comparaison randomisée protocole long-protocole court dans les stimulations de l'ovaire en association avec un agoniste de la GnRH en vue de fecondation in vitro. Contracept Fertil Sexual 1988;16:624–627Google Scholar
- 15.Tan SL, Kingsland C, Cambell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810–814PubMedGoogle Scholar
- 16.Remorgida V, Anserini P, Crose S, Costa M, Ferrailo A, Centonze A, Gaggero G, Capitanio G: The duration of pituitary suppression by means of intranasal gonadotropin-releasing hormone administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program. J Vitro Fertil Embryo Transfer 1989;6:76–80CrossRefGoogle Scholar
- 19.Meldrum D, Steingold K, de Ziegler D, Chetkowski R, Hamilton F, Randle D: Influence of the resting state of the ovary on recruitment of multiple follicles for IVF/ET. 4th World Conference on in Vitro Fertilization, Melbourne, Australia, 1985, abstr 188Google Scholar
- 20.Loumaye E, Vankrieten L, Depreester S, Psalti I, de Cooman S, Thomas K: Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. Fertil Steril 1989;51:105–111PubMedGoogle Scholar